JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Louie, A. K.
Right arrow Articles by Loh, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Louie, A. K.
Right arrow Articles by Loh, H. H.

Attenuation of opioid receptor activity by phorbol esters in neuroblastoma x glioma NG108-15 hybrid cells

AK Louie, ES Bass, J Zhan, PY Law and HH Loh

Department of Psychiatry, Langley Porter Psychiatric Institute, San Francisco, California.

Chronic opioid treatment of neuroblastoma x glioma NG108-15 cells induces desensitization of the opioid receptor and this may involve a change in membrane protein phosphorylation. In an attempt to mimic this possible mechanism, we studied effects of phorbol ester activation of protein kinase C on opioid receptor activity. Incubation of NG108-15 hybrid cells with the phorbol ester 12-O-tetradecanoylphorbol-13- acetate (TPA) abolished up to 45% of opioid inhibition of cyclic AMP accumulation in intact cells, while basal accumulation and prostaglandin E1-stimulated cyclic AMP accumulation were unaltered. This decrease of opioid inhibition was dose- and time-dependent and the potency order of phorbol esters and apparent K activation (90 nM) for TPA were consistent with phorbol esters acting through the stimulation of protein kinase C. TPA also decreased the inhibition of cyclic AMP accumulation mediated through muscarinic and alpha-2 adrenergic receptors. These effects of TPA were best explained by a TPA-induced alteration of the inhibitory nucleotide-binding protein (Gi), the common transducer protein of these receptors. Impairment of Gi by TPA treatment was evidenced by a reduction in agonist-stimulated GTP hydrolysis and activation by GTP. Quantification of Gi by pertussis toxin-catalyzed ADP-ribosylation revealed that TPA decreased maximal labeling. In summary, phorbol esters appeared to attenuate opioid receptor activity by altering the activity of the transducer protein Gi.

Volume 253, Issue 1, pp. 401-407, 04/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
Z. Y. Wei and S. C. Roerig
Spinal Morphine/Clonidine Antinociceptive Synergism is Regulated by Protein Kinase C, but not Protein Kinase A Activity
J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 937 - 943.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
Y.-C. Cai, L. Ma, G.-H. Fan, J. Zhao, L.-Z. Jiang, and G. Pei
Activation of N-Methyl-D-Aspartate Receptor Attenuates Acute Responsiveness of delta -Opioid Receptors
Mol. Pharmacol., April 1, 1997; 51(4): 583 - 587.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
B. Xiang, G.-H. Yu, J. Guo, L. Chen, W. Hu, G. Pei, and L. Ma
Heterologous Activation of Protein Kinase C Stimulates Phosphorylation of delta -Opioid Receptor at Serine 344, Resulting in beta -Arrestin- and Clathrin-mediated Receptor Internalization
J. Biol. Chem., February 9, 2001; 276(7): 4709 - 4716.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics.